Serialization: What It Means for Pharmaceutical Manufacturing

Posted by Peter Lunde

In the pharmaceutical industry, counterfeit and falsified drugs pose a global public health risk. These drugs may be not only ineffective but actively dangerous, causing adverse reactions or even death. Furthermore, these counterfeit drugs may be manufactured in multiple locations — e.g., chemical synthesis in one country, the addition of fillers in another and packaging in a third — making them difficult to track and remove from the supply chain.


Topics: packaging, serialization